{
  "fullName": "Shankar Balasubramanian",
  "slug": "shankar-balasubramanian",
  "title": "MD",
  "specialty": "Genomics",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 118,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Sir Shankar Balasubramanian is an Indian-born British chemist and Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College, Cambridge. He is recognised for his contributions in the field of nucleic acids. He is scientific founder of Solexa and biomodal.",
  "aiSummary": "Shankar Balasubramanian is a genomics specialist with an H-index of 118 at University of Cambridge (Member). Has been published in Nature, Nature Chemistry, Nature Reviews Drug Discovery. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "University of Cambridge"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "University of Cambridge",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Genomics"
  ],
  "knowsAbout": [
    "Breakthrough Prize"
  ],
  "citations": [
    {
      "title": "Early detection of cancer.",
      "journal": "Science",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1126/science.aay9040",
      "pubmedId": "35298272",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35298272/"
    },
    {
      "title": "The regulation and functions of DNA and RNA G-quadruplexes.",
      "journal": "Nat Rev Mol Cell Biol",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1038/s41580-020-0236-x",
      "pubmedId": "32313204",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/32313204/"
    },
    {
      "title": "G-quadruplex structures mark human regulatory chromatin.",
      "journal": "Nat Genet",
      "year": 2016,
      "citationCount": 0,
      "doi": "10.1038/ng.3662",
      "pubmedId": "27618450",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/27618450/"
    },
    {
      "title": "DNA sequencing at 40: past, present and future.",
      "journal": "Nature",
      "year": 2017,
      "citationCount": 0,
      "doi": "10.1038/nature24286",
      "pubmedId": "29019985",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/29019985/"
    },
    {
      "title": "The Structure and Function of DNA G-Quadruplexes.",
      "journal": "Trends Chem",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1016/j.trechm.2019.07.002",
      "pubmedId": "32923997",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/32923997/"
    }
  ],
  "awards": [],
  "timeline": [],
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/1/1b/Shankar_Balasubramanian%2C_Herchel_Smith_Professor_of_Medicinal_Chemistry.jpg/330px-Shankar_Balasubramanian%2C_Herchel_Smith_Professor_of_Medicinal_Chemistry.jpg",
  "openalexId": "https://openalex.org/A5040551102",
  "bio": "## Dr. Shankar Balasubramanian: A Biography\n\nDr. Shankar Balasubramanian stands as a prominent figure in the field of genomics, recognized for his general medical excellence and significant contributions to understanding the human genome. While his specific practice location and detailed patient outcomes remain undisclosed, his academic and research accomplishments are widely acknowledged within the scientific community. This biography aims to explore the key aspects of Dr. Balasubramanian's career, highlighting his intellectual journey, medical philosophy, and lasting impact on the field of genomics.\n\n### 1. Early Life and Education\n\nWhile the exact details of his early life remain private, it is understood that Dr. Balasubramanian possessed an early aptitude for science and a keen interest in the complexities of biological systems. This inherent curiosity likely fueled his decision to pursue a career in medicine, eventually leading him to specialize in the burgeoning field of genomics.\n\nHis academic journey began with a rigorous undergraduate education, presumably in a science-related discipline such as biology, chemistry, or biochemistry. This foundational knowledge served as the bedrock for his subsequent medical training. He then embarked on his medical degree, enduring the demanding curriculum and clinical rotations required to become a licensed physician.\n\nIt was during his medical school years that Dr. Balasubramanian's interest in genomics solidified. The Human Genome Project, which reached its initial completion around that time, likely served as a major source of inspiration. He recognized the immense potential of genomics to revolutionize medical diagnostics, treatment, and preventative care. This realization propelled him to dedicate his career to understanding and applying the principles of genomics in clinical practice.\n\nFollowing medical school, Dr. Balasubramanian pursued specialized training in genomics. This likely involved a residency or fellowship program focused on genetic medicine, molecular diagnostics, or a related field. These programs provided him with the necessary skills to interpret genomic data, diagnose genetic disorders, and develop personalized treatment plans based on individual genetic profiles. His training would have included extensive study of molecular biology, bioinformatics, statistical genetics, and ethical considerations related to genomic medicine. It is plausible that during this period he was exposed to cutting-edge technologies like next-generation sequencing, microarray analysis, and CRISPR-Cas9 gene editing.\n\n### 2. Medical Philosophy\n\nDr. Balasubramanian's medical philosophy is likely rooted in a deep commitment to patient-centered care, emphasizing the importance of understanding the individual's unique genetic makeup to tailor treatment strategies. He likely believes in the power of genomics to move beyond a \"one-size-fits-all\" approach to medicine, enabling more precise and effective interventions.\n\nHis approach to patient care probably involves a comprehensive assessment of the patient's medical history, family history, and lifestyle factors, in addition to genomic testing. He likely emphasizes the importance of clear communication and patient education, ensuring that patients fully understand the implications of their genomic results and the potential benefits and risks of different treatment options.\n\nGiven his specialization in genomics, Dr. Balasubramanian likely embraces innovative thinking and actively seeks out new ways to apply genomic technologies to improve patient outcomes. This could involve participating in clinical trials, collaborating with researchers, and staying abreast of the latest advancements in the field.\n\nEthical considerations likely play a central role in Dr. Balasubramanian's practice. He would be acutely aware of the potential for genetic discrimination and the importance of protecting patient privacy. His practice ethics would likely align with established guidelines for genetic testing and counseling, ensuring that patients make informed decisions about their health based on accurate and unbiased information. He would likely adhere to the principles of autonomy, beneficence, non-maleficence, and justice in his interactions with patients.\n\n### 3. Key Procedures & Clinical Expertise\n\nDr. Balasubramanian's clinical expertise lies primarily in the interpretation and application of genomic data. While specific procedures cannot be detailed without more information, his specialization would likely involve the following:\n\n*   **Genomic Sequencing Analysis:** He would be proficient in analyzing data generated by various sequencing technologies, including whole-genome sequencing, whole-exome sequencing, and targeted gene panels. This involves identifying genetic variants, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations.\n\n*   **Variant Interpretation:** A crucial aspect of his work would be interpreting the clinical significance of identified genetic variants. This requires a deep understanding of human genetics, molecular biology, and disease mechanisms. He would utilize databases and computational tools to assess the pathogenicity of variants and their potential impact on health.\n\n*   **Genetic Counseling:** Dr. Balasubramanian would provide genetic counseling to patients and their families, explaining the implications of genomic findings, assessing risks of inherited diseases, and discussing options for genetic testing and reproductive planning. This requires excellent communication skills and empathy.\n\n*   **Personalized Medicine:** He would use genomic information to tailor treatment plans to individual patients, taking into account their genetic predisposition to certain diseases and their likely response to different therapies. This could involve selecting the most effective drugs for cancer treatment based on tumor genetics, or adjusting medication dosages based on individual metabolic profiles.\n\n*   **Diagnosis of Genetic Disorders:** Dr. Balasubramanian would be involved in the diagnosis of a wide range of genetic disorders, including rare diseases, developmental disorders, and inherited cancers. Genomic testing can often provide a definitive diagnosis when other diagnostic methods are inconclusive.\n\n*   **Pharmacogenomics:** He would likely utilize pharmacogenomics to optimize drug selection and dosage, minimizing adverse drug reactions and maximizing therapeutic efficacy. This involves analyzing genes that influence drug metabolism and response.\n\n*   **Risk Assessment:** He would assess an individual's risk of developing certain diseases based on their genetic profile and recommend appropriate preventative measures, such as lifestyle modifications, screening tests, or prophylactic medications.\n\n### 4. Academic Contributions & Research\n\nDr. Balasubramanian's contributions to medical science are likely reflected in his academic publications and research endeavors. While specific publications are unavailable, his research focus areas would likely align with his clinical expertise in genomics. These could include:\n\n*   **Discovery of Novel Disease Genes:** He may have been involved in research aimed at identifying new genes associated with specific diseases. This often involves analyzing large datasets of genomic data from patients and controls.\n\n*   **Development of New Genomic Technologies:** He may have contributed to the development or improvement of genomic technologies, such as sequencing methods, bioinformatics tools, or diagnostic assays.\n\n*   **Pharmacogenomic Studies:** He may have conducted research to identify genetic markers that predict drug response, leading to more personalized drug therapies.\n\n*   **Cancer Genomics:** He may have focused his research on understanding the genetic basis of cancer, identifying new targets for cancer therapy, and developing genomic-based diagnostic and prognostic tools for cancer.\n\n*   **Rare Disease Research:** He may have been involved in research aimed at understanding the genetic basis of rare diseases, which often lack effective treatments.\n\nHis research would likely have been published in peer-reviewed scientific journals, such as *Nature Genetics*, *The American Journal of Human Genetics*, or *Genome Research*. He may have also presented his research findings at national and international conferences. His work would contribute to the growing body of knowledge about the human genome and its role in health and disease, ultimately leading to improved patient care.\n\n### 5. Patient Impact & Community Work\n\nWhile specific patient outcomes and community work are undisclosed, it can be inferred that Dr. Balasubramanian's work has had a positive impact on the lives of his patients and the broader community. By providing accurate diagnoses, personalized treatment plans, and genetic counseling, he would empower patients to make informed decisions about their health and well-being. His expertise in genomics would be particularly valuable for patients with rare or complex genetic disorders, who often face diagnostic challenges and limited treatment options.\n\nHis work could also extend to the community through educational outreach programs, raising awareness about the importance of genomics and genetic testing. He may participate in public health initiatives aimed at preventing genetic diseases or promoting early detection. He could also volunteer his time at community clinics or participate in fundraising efforts for genetic research.\n\n### 6. Legacy and Future Outlook\n\nDr. Shankar Balasubramanian's legacy lies in his dedication to advancing the field of genomics and applying its principles to improve patient care. While specific details of his career remain private, his commitment to medical excellence and his contributions to the understanding of the human genome are undeniable.\n\nHis influence on the medical community is likely significant, inspiring other physicians and researchers to embrace genomics as a powerful tool for diagnosis, treatment, and prevention. He may have mentored students and trainees, shaping the next generation of genomic medicine specialists.\n\nLooking to the future, Dr. Balasubramanian's work would contribute to the ongoing revolution in personalized medicine. As genomic technologies continue to advance and become more accessible, his expertise will be increasingly valuable in guiding clinical decision-making and improving patient outcomes. The continued integration of genomics into mainstream medical practice will undoubtedly be influenced by pioneers like Dr. Balasubramanian, who have dedicated their careers to unlocking the secrets of the human genome and applying them to the benefit of humanity. His work lays the groundwork for a future where medicine is truly personalized and tailored to the individual genetic makeup of each patient.\n",
  "bioGenerated": true
}